Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other financing activities: 2012-2019

Historic Other financing activities for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Dec 2019 value amounting to $615,000.

  • EyePoint Pharmaceuticals' Other financing activities rose 140.59% to $615,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.3 million, marking a year-over-year increase of 88.34%. This contributed to the annual value of -$4.5 million for FY2024, which is 1100.44% down from last year.
  • According to the latest figures from Q4 2019, EyePoint Pharmaceuticals' Other financing activities is $615,000, which was down 31.21% from $894,000 recorded in Q1 2019.
  • EyePoint Pharmaceuticals' Other financing activities' 5-year high stood at $1.3 million during Q3 2018, with a 5-year trough of -$1.5 million in Q4 2018.
  • Over the past 2 years, EyePoint Pharmaceuticals' median Other financing activities value was $754,500 (recorded in 2019), while the average stood at $370,167.
  • Within the past 5 years, the most significant YoY rise in EyePoint Pharmaceuticals' Other financing activities was 140.59% (2019), while the steepest drop was 1.22% (2019).
  • EyePoint Pharmaceuticals' Other financing activities (Quarterly) stood at -$1.5 million in 2018, then surged by 140.59% to $615,000 in 2019.
  • Its Other financing activities stands at $615,000 for Q4 2019, versus $894,000 for Q1 2019 and -$1.5 million for Q4 2018.